Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SMS Pharmaceuticals Limited ( (IN:SMSPHARMA) ) has provided an update.
SMS Pharmaceuticals Limited has notified stock exchanges that, pursuant to a recent SEBI circular, a special window has been re-opened for re-lodgement of physical share transfer requests. The facility applies only to transfer deeds originally lodged before April 1, 2019 that were rejected, returned or not processed due to documentation or procedural deficiencies.
The special window will remain available for one year, from February 5, 2026 to February 4, 2027, allowing affected shareholders a defined period to regularise legacy physical transfer requests. This move is expected to help clear residual issues from the earlier transition away from physical transfers, improving share transfer compliance and potentially reducing investor grievances linked to old, unresolved physical share transactions.
More about SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an Indian pharmaceutical company focused on manufacturing and supplying active pharmaceutical ingredients and related pharmaceutical products. Its securities are listed on both BSE and the National Stock Exchange of India, giving it access to a broad base of public equity investors in the domestic capital markets.
Average Trading Volume: 14,603
Technical Sentiment Signal: Buy
Current Market Cap: 34.3B INR
For a thorough assessment of SMSPHARMA stock, go to TipRanks’ Stock Analysis page.